A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines

BACKGROUND: The urokinase receptor (uPAR) mediates a diverse array of cellular processes including several events involved in prostate cancer metastasis. Many of these activities are initiated or enhanced by uPAR binding to its proteolytic ligand, urokinase (uPA). Our objective in this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasanuzzaman, Mohammad, Kutner, Robert, Agha-Mohammadi, Siamak, Reiser, Jakob, Sehgal, Inder
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885813/
https://www.ncbi.nlm.nih.gov/pubmed/17509140
http://dx.doi.org/10.1186/1476-4598-6-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885813/
https://www.ncbi.nlm.nih.gov/pubmed/17509140
http://dx.doi.org/10.1186/1476-4598-6-34

Ejemplares similares